Effect ofcis-Platinum on Heme, Drug, and Steroid Metabolism Pathways: Possible Involvement in Nephrotoxicity and Infertility

References

• Maines M. D., Mayer R. Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis bycis-platinum: reversal by human chorionic gonadotropin. J. Biol. Chem. 1985; 260: 6063
   PubMed Web of Science ®Google Scholar
• Jollie D. R., Maines M. D. Effect ofcis-platinum on kidney cytochrome P-450 and heme metabolism: evidence for the regulatory role of the pituitary hormone. Arch. Biochem. Biophys. 1985; 240: 51
   PubMed Web of Science ®Google Scholar
• Maines M. D. Differential effect ofcis-platinum (cis-diammine-dichloroplatinum) on regulation of liver and kidney heme and hemoprotein metabolism: possible involvement of γ-glutamyl cycle enzymes. Biochem. J. 1986; 237: 713
   PubMed Web of Science ®Google Scholar
• Iscan M., Maines M. D. Differential regulation of heme and drug metabolism in rat testis and prostate: response tocis-platinum and human chorionic gonadotropin. J. Pharmacol. Exp. Ther. 1990; 253: 73
   PubMed Web of Science ®Google Scholar
• Maines M. D., Sluss P. M., Iscan M. cis-platinum-mediated depression of LH receptors and cytochrome P-450scc in rat Leydig cells: a possible mechanism for decrease in serum testosterone. Endocrinology 1990; 126: 2398
   PubMed Web of Science ®Google Scholar
• Granick S. The inductionin vitro of the synthesis of δ-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J. Biol. Chem. 1966; 241: 1359
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos P. G., Mode A., Norstedt G., Gustafsson J. A. Regulation of sexual differentiation in drug and steroid metabolism. Trends Pharmacol. Sci. 1989; 10: 149
   PubMed Web of Science ®Google Scholar
• Rosenberg B., VanCamp L., Trosko J. E., Mansour V. H. Platinum compounds: a new class of potent antitumor agents. Nature 1969; 222: 385
   PubMed Web of Science ®Google Scholar
• Loehrer P. J., Einhorn L. H. cisPlatin. Ann. Intern. Med. 1984; 100: 704
   PubMed Web of Science ®Google Scholar
• Eastman A., Barry M. A. Interaction oftrans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry 1987; 26: 3303
   PubMed Web of Science ®Google Scholar
• Harder H. C., Smith R. G., Leroy A. F. Template primer inactivation bycis-dichlorodiammine andtrans-dichlorodiammine-platinum for human DNA-polymerase alpha, beta, and Rauscher murine leukemis virus reverse-transcriptase, as a mechanism of cytotoxicity. Cancer Res. 1976; 36: 3821
   PubMed Web of Science ®Google Scholar
• Mansy S., Chu G. Y. H., Duncan R. E., Tobias R. S. Heavy metal nucleotide interactions. XII. Competitive reactions in systems of four nucleotides withcis- andtrans-diammineplatinum (II). Raman difference spectrophotometric determination of the relative nucleophilicity of guanosine, cytidine, adenosine, and uridine monophosphates as well as the analogous bases in DNA. J. Am. Chem. Soc. 1978; 100: 607
   Web of Science ®Google Scholar
• Melius P., Friedman M. E. Complexes of platinum with polypeptides and proteins. Inorg. Perspect. Biol. Med. 1977; 1: 1
   Web of Science ®Google Scholar
• Litterst C. L. Plasma pharmacokinetics, urinary excretion, and tissue distribution of platinum following i.v. administration of cyclobutanedicarboxylatoplatinum(II) andcis-platinum to rabbits. Platinum Coordination Complexes in Cancer Chemotherapy, Developments in Oncology Series, M. P. Hacker, E. B. Douple, I. W. Krakoff. Martinus Nijhoff, Boston, 71
   Google Scholar
• Litterst C. L., LeRoy A. F., Guarino A. M. Disposition and distribution of platinum following parenteral administration ofcis-dichlorodiammineplatinum(II) to animals. Cancer Treat. Rep. 1979; 63: 1485
   PubMedGoogle Scholar
• Stewart D. J., Leavens M., Maor M., Feun L., Luna M., Bonura J., Caprioli R., Loo T. L., Benjamin R. S. Human central nervous system distribution ofcis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res. 1982; 42: 2474
   PubMed Web of Science ®Google Scholar
• Daley-Yates P. T., McBrien D. C. H. The renal fractional clearance of platinum antitumor compounds in relation to nephrotoxicity. Biochem. Pharmacol. 1985; 34: 1423
   PubMed Web of Science ®Google Scholar
• Gullo J. J., Litterst C. L., Maguire P. J., Sikic B. I., Hoth D. F., Woolley P. V. Pharmacokinetics and protein binding ofcis-dichlorodiammine platinum(II) administered as a one hour or as a twenty hour infusion. Cancer Chemother. Pharmacol. 1980; 5: 21
   PubMed Web of Science ®Google Scholar
• Litterst C. L. Alterations in the toxicity ofcis-dichlorodiammineplatinum(II) and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration. Toxicol. Appl. Pharmacol. 1981; 61: 99
   PubMed Web of Science ®Google Scholar
• Griffith O. W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 1979; 254: 7558
   PubMed Web of Science ®Google Scholar
• De Graeff A., Slebos R. J. C., Rodenhuis S. Resistance tocisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemother. Pharmacol. 1988; 22: 325
   PubMed Web of Science ®Google Scholar
• Maines M. D., Mayer R. D. Promotion oftrans-platinumin vivo effects on renal heme and hemoprotein metabolism by d,l-buthionine-S,R-sulfoximine: possible role of glutathione. Biochem. Pharmacol. 1990; 39: 1565
   PubMed Web of Science ®Google Scholar
• Andrews P. A., Murphy M. P., Howell S. B. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res. 1985; 45: 6250
   PubMed Web of Science ®Google Scholar
• Maines M. D. New developments in the regulation of heme metabolism and their implications. CRC Crit. Rev. Toxicol. 1984; 12: 241
   Web of Science ®Google Scholar
• Grandchamp B., Nordman M. Enzymes of heme biosynthesis pathway: recent advances in molecular genetics. Semin. Hematol. 1988; 25: 303
   PubMed Web of Science ®Google Scholar
• Sassa S. Heme stimulation of cellular growth and differentiation. Semin. Hematol. 1988; 25: 312
   PubMed Web of Science ®Google Scholar
• Woods J. S. Regulation of porphyrin and heme metabolism in the kidney. Semin. Hematol. 1988; 25: 336
   PubMed Web of Science ®Google Scholar
• Shemin D., Rittenberg D. The biological utilization of glycine for the synthesis of the protoporphyrin of hemoglobin. J. Biol. Chem. 1946; 166: 621
   PubMed Web of Science ®Google Scholar
• Granick S., Sinclair P., Sassa S., Grieninger G. Effects of heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium and a spectrofluometric assay for porphyrin composition. J. Biol. Chem. 1975; 250: 9215
   PubMed Web of Science ®Google Scholar
• Maines M. D., Kappas A. Enzymes of heme metabolism in the kidney: regulation by trace metals which do not form heme complexes. J. Exp. Med. 1977; 146: 1286
   PubMed Web of Science ®Google Scholar
• Sassa S., Granick S., Kappas A. Effect of lead and genetic factors on heme biosynthesis in the human red cell. Ann. N.Y. Acad. Sci. 1975; 244: 419
   PubMed Web of Science ®Google Scholar
• Meyer H. A., Strand L. J., Doss M., Rees A. C., Marver H. S. Intermittent acute porphyria-demonstration of a genetic defect in porphobilinogen metabolism. N. Engl. J. Med. 1972; 286: 1277
   PubMed Web of Science ®Google Scholar
• Alexopoulos C. G., Chalevelakis G., Katsoulis C., Pallikaris G. Adverse effect ofcis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man. Cancer Chemother. Pharmacol. 1986; 17: 165
   PubMed Web of Science ®Google Scholar
• Von Hoff D. D., Schilsky R., Richert C. M., Reddick R. L., Rozenweig M., Young R. C., Muggia F. M. Toxic effects ofcis-dichlorodiammine platinum II, in man. Cancer Treat. Rep. 1979; 63: 1527
   PubMedGoogle Scholar
• Tenhunen R., Marver H. S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 1968; 61: 748
   PubMed Web of Science ®Google Scholar
• Docherty J. C., Firneisz G. D., Schacter B. A. Methene bridge carbon atom elimination in oxidative heme degradation catcalyzed by heme oxygenase and NADPH-cytochrome P-450 reductase. Arch. Biochem. Biophys. 1984; 235: 657
   PubMed Web of Science ®Google Scholar
• O'Carra P. Heme cleavage: biological systems and chemical analogs. Porphyrins and Metalloporphyrins, K. M. Smith. Elsevier, Amsterdam 1975; 123
   Google Scholar
• Brown S. B., King R. F. G. J. The mechanism of heme catabolism, bilirubin formation in living rats by18O-oxygen labelling. Biochem. J. 1978; 170: 297
   PubMed Web of Science ®Google Scholar
• Docberty J. C., Schacter B. A., Firneisz G. D., Brown S. B. Mechanism of action of heme oxygenase. A study of heme degradation to bile pigment by18O labeling. J. Biol. Chem. 1984; 259: 13066
   PubMed Web of Science ®Google Scholar
• Itano H. A., Hirota T. A. A two-molecule mechanism of haem degradation. Biochem. J. 1985; 226: 767
   PubMed Web of Science ®Google Scholar
• Master B. S. S., Schacter B. A. The catalysis of heme degradation by purified NADPH-cytochrome c reductase in the absence of other microsomal proteins. Am. Clin. Res. 1976; 8: 18, (Suppl. 17)
   Google Scholar
• Maines M. D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988; 2: 2557
   PubMed Web of Science ®Google Scholar
• Maines M. D., Trakshel G. M., Kutty R. K. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: only one molecular species of the enzyme is inducible. J. Biol. Chem. 1986; 261: 411
   PubMed Web of Science ®Google Scholar
• Trakshel G. M., Kutty R. K., Maines M. D. Purification and characterization of the major constitutive form of testicular heme oxygenase: the non-inducible isoform. J. Biol. Chem. 1986; 261: 11131
   PubMed Web of Science ®Google Scholar
• Trakshel G. M., Maines M. D. Detection of two heme oxygenase isoforms in the human testis. Biochem. Biophys. Res. Commun. 1988; 154: 285
   PubMed Web of Science ®Google Scholar
• Cruse I., Maines M. D. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J. Biol. Chem. 1988; 263: 3348
   PubMed Web of Science ®Google Scholar
• Trakshel G. M., Maines M. D. Multiplicity of heme oxygenase isozymes-HO-1 and HO-2 are different molecular species in rat and rabbits. J. Biol. Chem. 1989; 264: 1323
   PubMed Web of Science ®Google Scholar
• Rotenberg M. O., Maines M. D. Isolation, characterization, and expression inE. coli of a cDNA encoding rat heme oxygenase-2. J. Biol. Chem. 1990; 265: 7501
   PubMed Web of Science ®Google Scholar
• Kikuchi G., Yoshida T. Function and induction of the microsomal heme oxygenase. Mol. Cell. Biochem. 1983; 53/54: 163
   PubMed Web of Science ®Google Scholar
• Sunderman F. W., Jr. Metal Induction of heme oxygenase. Ann. N. Y. Acad. Sci. 1987; 514: 65
   PubMed Web of Science ®Google Scholar
• Abraham N. G., Lin J. H., Schwartzman M. L., Levere R. D., Shibahara S. The physiological significance of heme oxygenase. Int. J. Biochem. 1988; 20: 543
   PubMedGoogle Scholar
• Schacter B. A. Heme catabolism by heme oxygenase: physiology, regulation, and mechanism of action. Semin. Hematol. 1988; 25: 349
   PubMed Web of Science ®Google Scholar
• Maines M. D., Chung A. S., Kutty R. K. Inhibition of testicular heme oxygenase activity by cadmium: a novel cellular response. J. Biol. Chem. 1982; 257: 14116
   PubMed Web of Science ®Google Scholar
• Trakshel G. M., Kutty R. K., Maines M. D. Cadmiummediated inhibition of testicular heme oxygenase activity: the role of NADPH-cytochrome c (P-450) reductase. Arch. Biochem. Biophys. 1986; 251: 175
   PubMed Web of Science ®Google Scholar
• Maines M. D. Zinc-protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim. Biophys. Acta 1981; 673: 339
   PubMed Web of Science ®Google Scholar
• Berglund L., Angelin B., Blomstrant R., Drummond G., Kappas A. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects. Hepatology 1988; 8: 625
   PubMed Web of Science ®Google Scholar
• Vreman H. J., Gillman M. J., Stevenson D. K. In vitro inhibition of adult rat intestinal heme oxygenase by metalloporphyrins. Pediatr. Res. 1989; 26: 362
   PubMed Web of Science ®Google Scholar
• Mayer R. D., Berman S., Cockett A. T. K., Maines M. D. Differential effects of cyclosporin of hepatic and renal heme, cytochrome P-450, and drug metabolism. Biochem. Pharmacol. 1989; 38: 1001
   PubMed Web of Science ®Google Scholar
• Kutty R. K., Maines M. D. Biliverdin reductase: characterization in the rat kidney and the inhibition of activity by mercuric chloride. Biochem. Pharmacol. 1983; 32: 2095
   PubMed Web of Science ®Google Scholar
• Huang T. J., Maines M. D. Bromobenzene-mediated alteration in activity and electrophoretic pattern of biliverdin reductase variants in rat kidney. Mol. Pharmacol. 1990; 37: 25
   PubMed Web of Science ®Google Scholar
• Kutty R. K., Maines M. D. Purification and characterization of biliverdin reductase from the rat liver. J. Biol. Chem. 1981; 256: 3956
   PubMed Web of Science ®Google Scholar
• Trakshel G. M., Maines M. D. Characterization of glutathione-S-transferases in rat kidney: alteration of composition bycis-platinum. Biochem. J. 1988; 252: 127
   PubMed Web of Science ®Google Scholar
• Sekura R., Meister A. γ-Glutamylcysteine synthetase, further purification, “half of the sites” reactivity, subunits, and specificity. J. Biol. Chem. 1977; 252: 2599
   PubMed Web of Science ®Google Scholar
• Meister A. On the cycles of glutathione metabolism and transport. Current Topics in Cellular Regulation, R. W. Estabrook, P. Srere. Academic Press, New York 1981, chap. 2.
   Google Scholar
• Chung A.-S., Maines M. D., Reynolds W. A. The inhibition of the enzymes of glutathione metabolism by mercuric chloride in the rat liver and kidney: protection by selenium. Biochem. Pharmacol. 1982; 31: 3093
   PubMed Web of Science ®Google Scholar
• Meister A. New aspects of glutathione biochemistry and transport: selective alteration of glutathione metabolism. Fed. Proc. 1984; 43: 3031
   PubMedGoogle Scholar
• Meister A., Tate S. S., Ross L. L. Membrane Bound Enzymes, A. Mortonasi. Plenum Press, New York 1976; Vol. 3: 315
   Google Scholar
• Tate S. S., Meister A. Interaction of γ-glutamyl transpeptidase with amino acids, dipeptides and derivatives and analogs of glutathione. J. Biol. Chem. 1974; 249: 7593
   PubMed Web of Science ®Google Scholar
• Mistry P., Lee C., McBrien D. C. H. Intracellular metabolites ofcisplatin in the rat kidney. Cancer Chemother. Pharmacol. 1989; 24: 73
   PubMed Web of Science ®Google Scholar
• Wung W. E., Howell S. B. Modulation of plasma cyst(e)ine bycis-platin. Eur. J. Cancer Clin. Oncol. 1983; 19: 915
   PubMedGoogle Scholar
• Daley-Yates P. T., McBrien D. C. H. The inhibition of renal ATPase bycisplatin and some biotransformation products. Chem. Biol. Interact. 1982; 40: 325
   PubMed Web of Science ®Google Scholar
• Lash L. H., Anders M. W. Cytotoxicity of S-(1–2,dichlorovinyl)-glutathione and S-(1,2-dichlorovinyl)-l-cysteine in isolated rat kidney cells. J. Biol. Chem. 1986; 261: 13076
   PubMed Web of Science ®Google Scholar
• Borch R. F., Pleasants M. E. Inhibition ofcis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 6611
   PubMed Web of Science ®Google Scholar
• Litterst C. L., Tong S., Hirokata Y., Siddik Z. H. Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agentcis-dichlorodiammineplatinum-II. Pharmacology 1983; 27: 46
   PubMedGoogle Scholar
• Srivastava G., Bawden M. J., Anderson A., May B. K. Drug induction of P450IIB1/IIB2 and 5-aminolevulinate synthase mRNAs in rat tissues. Biochim. Biophys. Acta 1989; 1007: 192
   PubMedGoogle Scholar
• LeBlanc G. A., Waxman D. J. Feminization of rat hepatic P-450 expression bycisplatin. J. Biol. Chem. 1988; 263: 15732
   PubMed Web of Science ®Google Scholar
• Bompart G. cis-Platin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex. Toxicol. Lett. 1989; 48: 193
   PubMed Web of Science ®Google Scholar
• Imaoka S., Tanaka S., Funae Y. ω- and (ω-1)-Hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. Biochem. Int. 1989; 18: 731
   PubMedGoogle Scholar
• Ellin A., Jakobsson S. V., Schenkman J. B., Orrenius S. Cytochrome P-450 of rat kidney cortex microsomes: its involvement in fatty acid ω- and (ω-1)-hydroxylation. Arch. Biochem. Biophys. 1972; 150: 64
   PubMed Web of Science ®Google Scholar
• Okita R. T., Parkhill L. K., Yasukochi Y., Masters B. S. S., Theoharides A. D., Kupfer D. The ω- and (ω-1)-hydroxylase activities of prostaglandins A1and E1 and lauric acid by pig kidney microsomes and a purified kidney cytochrome P-450. J. Biol. Chem. 1981; 256: 5962
   Web of Science ®Google Scholar
• Capdevila J., Marnett L. J., Chacos N., Prough R. A., Estabrook R. W. Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyeicosatetraenoic acids. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 767
   PubMed Web of Science ®Google Scholar
• DeLuca H. F. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J. 1988; 2: 224
   PubMed Web of Science ®Google Scholar
• Sharma R. K., Doig M. V., Lewis D. F. V., Gibson G. C. Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 1989; 38: 3621
   PubMed Web of Science ®Google Scholar
• Ullrich V., Haurand M. Thromboxane synthase as a cytochrome P-450 enzyme. Advances in Prostaglandin Thromboxane Leukotriene Research, B. Samuelson, R. Paoletti, P. W. Ramwell. Raven Press, New York 1983; Vol. 11: 105
   Google Scholar
• Coffman T. M., Carr D. R., Yarger W. E., Klotman T. E. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporin nephrotoxicity. Transplantation 1987; 43: 282
   PubMed Web of Science ®Google Scholar
• Schwartzman M. L., Abraham N. G., Masferrer J., Dunn M. W., McGiff J. C. Cytochrome P450-dependent archidonate metabolism in corneal epithelium: formation of biologically active compounds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, B. Samuelsson, R. Paoletti, P. W. Ramwell. Raven Press, New York 1987; Vol. 17A: 78
   Google Scholar
• Muirhead E. E. Antihypertensive functions of the kidney. Hypertension 1980; 2: 444
   PubMed Web of Science ®Google Scholar
• Muirhead E. E., Byers L. W., Capdevila J., Brooks B., Pitcock J. A., Brown P. S. The renal antihypertensive endocrine function: its relation to cytochrome P-450. J. Hypertension 1989; 7: 361
   PubMed Web of Science ®Google Scholar
• Schwartzman M., Carroll M. A., Ibraham N. G., Ferreri N. R., Songu-Mize E., McGiff J. C. Renal arachidonic acid metabolism the third pathway. Hypertension 1985; 7: 136, (Suppl. 1)
   Web of Science ®Google Scholar
• Sonderfan A. J., Arlotto M. P., Parkinson A. Identification of the cytochrome P-450 isozymes responsible for testosterone oxidation in rat lung, kidney, and testis: evidence that cytochrome P-450a (P450IIA1) is the physiologically important testosterone 7α-hydroxylase in rat testis. Endocrinology 1989; 125: 857
   PubMed Web of Science ®Google Scholar
• Ozols J., Stritmatter P. The reactivity of the lysyl residues of cytochrome b5. J. Biol. Chem. 1966; 241: 4793
   PubMed Web of Science ®Google Scholar
• Bussmann L., Franklin M., Samuels L. T. The environment of cytochrome P-450 in testicular microsomes. Acta Physiol. Lot. Am. 1980; 30: 171
   PubMedGoogle Scholar
• Purvis J. L., Canick J. A., Latif S. A., Rosenbaum J. H., Hologgitas J., Menard J. H. Control of cytochrome P-450 in rat testis mitochondria by human chorionic gonadotropin. Arch. Biochem. Biophys. 1973; 159: 31
   PubMed Web of Science ®Google Scholar
• Maines M. D., Jollie D. R. Dissociation of heme metabolic activities from the microsomal cytochrome P-450 turnover in testis of hypophysectomized rats. J. Biol. Chem. 1984; 259: 9557
   PubMed Web of Science ®Google Scholar
• Hauger R. L., Chen Y. I., Kelch R. P., Payne A. H. Pituitary regulation of Leydig cell function in the adult male rat. J. Endocrinol. 1977; 74: 57
   PubMed Web of Science ®Google Scholar
• DeKretser D. M., Catt K. J., Paulsen C. A. Studies on thein vitro testicular binding of iodinated luteinizing hormones in rats. Endocrinology 1971; 88: 332
   PubMed Web of Science ®Google Scholar
• Puett D., Ascoli M., Holladay L. A. Conformational and Metabolic Aspects of Gonadotropins. Hormone Binding and Target Cell Activation in the Testis, Current Topics in Molecular Endocrinology, Vol. 1, M. L. Dufau, A. R. Means. Plenum Press, New York 1974, chap. 6.
   Google Scholar
• Baksi S. N., Kenny A. D. Does estradiol stimulatein vivo production of 1,25-dihydroxyvitamin D3 in the rat. Life Sci. 1978; 22: 787
   PubMed Web of Science ®Google Scholar
• Tanaka Y., Castillo L., DeLuca H. F. Control of renal vitamin D hydroxylase in birds by sex hormones. Proc. Natl. Acad. Sci. U.S.A. 1976; 73: 2701
   PubMed Web of Science ®Google Scholar
• Reed E., Litterst C. L., Thill C. C., Yuspa S. H., Poirier M. C. cis-Diamminedichloroplatinum(II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats. Cancer Res. 1987; 47: 718
   PubMed Web of Science ®Google Scholar
• Appenroth D., Bräunlich H. Age differences incis-platinum nephrotoxicity. Toxicology 1984; 32: 343
   PubMed Web of Science ®Google Scholar
• Kramer R. E., Greiner J. W., Rumbaugh R. C., Sweeney T. D., Colby H. D. Requirement of the pituitary gland for gonadal hormone effects on hepatic drug metabolism in rats. J. Pharmacol. Exp. Ther. 1979; 208: 19
   PubMed Web of Science ®Google Scholar
• Gorski J. R., Arlotto M. P., Klaassen C. D., Parkinson A. Age- and sex-dependent induction of liver microsomal benzo(a)pyrene hydroxylase activity in rats treated with pregnenolone- 16α-carbonitrile (PCN). Carcinogenesis 1985; 6: 617
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Pasanen M., Kuha H., Gachalyi B., Kairaluoma M., Sotaniemi E. A., Park S. S., Friedman F. K., Gelboin H. V. The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies. Br. J. Clin. Pharmacol. 1986; 22: 125
   PubMed Web of Science ®Google Scholar
• Bjelogrlic N., Iscan M., Raunio H., Pelkonen O., Vahakangas K. Benzo(a)pyrene-DNA-adducts and monooxygenase activities in mice treated with benzo(a)pyrene, cigarette smoke, or cigarette smoke condensate. Chem. Biol. Interact. 1989; 70: 51
   PubMed Web of Science ®Google Scholar
• Lee I. P., Suzuki K. Induction of aryl hydrocarbon hydroxylase activity in the rat prostate glands by 2,3,7,8-tetrachloro-dibenzo-o-dioxin. J. Pharmacol. Ther. 1980; 215: 601
   PubMed Web of Science ®Google Scholar
• Whitlock J. P., Jr. The regulation of cytochrome P-450 gene expression. Annu. Rev. Pharmacol. Toxicol. 1986; 26: 333
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Eisen H. J., Negishi M., Lang M. A., Hjelmeland L. M. Genetic mechanisms controlling the induction of poly substrate monooxygenase (P-450) activities. Annu. Rev. Pharmacol. Toxicol. 1981; 21: 431–462
   PubMed Web of Science ®Google Scholar
• Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982; 22: 517
   PubMed Web of Science ®Google Scholar
• Morris I. D., Shalet S. M. Endocrine-mediated protection from cytotoxic-induced testicular damage. J. Endocrinol. 1989; 120: 7
   PubMed Web of Science ®Google Scholar
• Roth B. J., Einhorn L. H., Greist A. Long-term complications ofcisplatin-based chemotherapy for testis cancer. Semin. Oncol. 1988; 15: 345
   PubMed Web of Science ®Google Scholar
• Jackson I. M. D. The releasing factors of the hypothalamus. Hormones and Evolution, E. J. W. Barrington. Robert Krieger, Huntington, NY 1979; 723
   Google Scholar
• Meistrich M. L., Finch M., Da Cunha M. F., Hacker U., Au W. W. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res. 1982; 42: 122
   PubMed Web of Science ®Google Scholar
• Pogach L. M., Lee Y., Gould S., Giglio W., Meyenhofer M., Huang H. F. S. Characterization ofcis-platinum-induced Sertoli cell dysfunction in rodents. Toxicol. Appl. Pharmacol. 1989; 98: 350
   PubMed Web of Science ®Google Scholar
• Omura T., Sanders E., Estabrook R. W., Cooper D. Y., Rosenthal O. Isolation from adrenal cortex of a none-heme iron protein and a flavoprotein functional as a reduced triphosphopyridine nucleotide-cytochrome P-450 reductase. Arch. Biochem. Biophys. 1966; 117: 660
   Web of Science ®Google Scholar
• Mason J. I., France J. T., Magness R. R., Murry B. A., Rosenfeld C. R. Ovine placental steroid 17α-hydroxylase/C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturition. J. Endocrinol. 1989; 122: 351
   PubMed Web of Science ®Google Scholar
• Thompson E. A., Jr., Siiteri P. K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J. Biol. Chem. 1974; 249: 5373
   PubMed Web of Science ®Google Scholar
• Canick J. A., Ryan K. K. Cytochrome P-450 and the aromatization of 16α-hydroxytestosterone and androstendione by human placental microsomes. Mol. Cell Endocrinol. 1976; 6: 105
   PubMed Web of Science ®Google Scholar
• Soderfan A. J., Parkinson A. Inhibition of steroid 5α-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 1988; 265: 208
   PubMed Web of Science ®Google Scholar
• Inano H., Suzuki K., Wakabayashi K., Tamaoki B.-I. Biological activities of 7α-hydroxylated C19-steroids and changes in rat testicular 7α-hydroxylase activity with gonadal status. Endocrinology 1973; 92: 22
   PubMed Web of Science ®Google Scholar
• Pont A., Williams P. L., Anthar S., Reitz R. E., Bochra C., Smith E. R., Stephens D. A. Ketoconazoie blocks testosterone synthesis. Arch. Intern. Med. 1982; 142: 2137
   PubMed Web of Science ®Google Scholar
• Pont A., Williams P. L., Loose D. S., Feldman D. S., Reitz R. E., Bochra C., Stephens D. A. Ketoconazoie inhibits adrenal steroid synthesis. Ann. Intern. Med. 1982; 97: 370
   PubMed Web of Science ®Google Scholar
• Malozowki S., Mericq V., Cassorla F. Effects of ketoconazole on rat ovarian steroidogenic enzymatic activities. Res. Commun. Chem. Pathol. Pharmacol. 1986; 52: 403
   PubMedGoogle Scholar
• De Felice R., Johnson D. G., Galgiani J. N. Gynecomastia with ketoconazole. Antimicrob. Agents Chemother. 1981; 19: 1073
   PubMed Web of Science ®Google Scholar
• Veltman J. C., Maines M. D. Alterations of heme, cytochrome P-450 and steroid metabolism by mercury in rat adrenals. Arch. Biochem. Biophys. 1986; 248: 467
   PubMed Web of Science ®Google Scholar
• Veltman J. C., Maines M. D. The regulatory effect of copper on rat adrenal cytochrome P-450 and steroid metabolism. Biochem. Pharmacol. 1986; 35: 2903
   PubMed Web of Science ®Google Scholar
• Carreau S., Papadopoulos V., Boujrad N., Drosdowsky M. A. Effects ofcisplatin and bleomycin on mature rat Leydig cell testosterone production. J. Ster. Biochem. 1988; 30: 449
   PubMedGoogle Scholar
• Conn P. M., Conti M., Harwood J. P., Dufau M. L., Catt K. J. Internalization of gonadotropin-receptor complex in ovarian luteal cells. Nature 1978; 274: 598
   PubMed Web of Science ®Google Scholar
• Dufau M. L., Baukal A. J., Catt K. J. Hormone-induced guanyl nucleotide binding and activation of adenylate cyclase in the Leydig ceil. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 5837
   PubMed Web of Science ®Google Scholar
• Catt K. J., DuFau M. L. Gonadotropin receptors and regulation of interstitial cell-function in testis. Receptors and Hormone Action, B. W. O'Mally, L. Birnbaumer. Academic Press, New York 1978; Vol. 3: 291
   Google Scholar
• Fritz I. B. Sites of action of androgens and follicle stimulating hormone on cells of the seminiferous tubule. Biochemical Actions of Hormones, G. Litwack. Academic Press, New York 1978; 249
   Google Scholar
• Buzek S. W., Sanborn B. M. Increase in testicular androgen receptor during sexual maturation in the rat. Biol. Reprod. 1988; 39: 39
   PubMed Web of Science ®Google Scholar
• Skinner M. K., Fetterolf P. M., Anthony C. T. Purification of a paracrine factor, P-Mod-S, produced by testicular peritubular cells that modulates Sertoli cell function. J. Biol. Chem. 1988; 263: 1
   PubMed Web of Science ®Google Scholar
• Anthony C. T., Kovacs W. J., Skinner M. K. Analysis of the androgen receptor in isolated testicular cell types with a microassay that uses an affinity ligand. Endocrinology 1989; 125: 2628
   PubMed Web of Science ®Google Scholar
• Veltman J. C., Maines M. D. Unpublished data
   Google Scholar
• Maines M. D. Unpublished observation
   Google Scholar